Celgene
NASDAQ: CELG
$108.24
+$0.00 (+0.0%)
Closing Price on November 22, 2019
CELG Articles
The top analyst upgrades, downgrades and other research calls from Friday include Baidu, Barclays, Celgene, HPE, Intel, Kimberly-Clark, Lululemon, PayPal and Stratasys.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Tuesday include Biogen, Carbonite, Celgene, Emerson Electric, Kinder Morgan, Netflix and UnitedHealth.
Published:
Last Updated:
The September 29 short interest data have been compared with the previous report, and short interest in the selected biotech stocks was mixed.
Published:
Last Updated:
Thursday was a strong day for the U.S. markets with all major exchanges hitting record all-time highs. Crude oil finally fought back and pushed back over $50, but it still could close out the week...
Published:
Last Updated:
The September 15 short interest data have been compared with the previous report, and short interest in all the selected biotech stocks increased.
Published:
Last Updated:
A new Jefferies research report features a new list of top growth stocks to buy, and the list is dominated by top technology and biotechnology companies.
Published:
Last Updated:
The August 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Published:
Last Updated:
According to Merrill Lynch, the health care sector should act as a good hedge against volatility. Even biotech was shown to offer growth at a reasonable price.
Published:
Last Updated:
Celgene received an update from the FDA early on Thursday. Although shares did not dip initially, this action could prove to be problematic for the biotech giant going forward.
Published:
Last Updated:
The August 15 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
Published:
Last Updated:
The July 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Monday include American Airlines, Celgene, Citigroup, Facebook, Hertz, Hilton and Ulta Beauty.
Published:
Last Updated:
The July 14 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Published:
Last Updated:
The June 30 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Published:
Last Updated:
The biotech industry has made a splash in 2017, outperforming practically all the broad markets. With this incredible display, it's no wonder that investor interest in this particular industry has...
Published:
Last Updated: